RNA Advisors is a team of financial advisors, strategy consultants, and valuation experts dedicated to companies and investors in the Life Sciences, Healthcare, and Technology sectors.
We are singularly focused on the science, the industry subsectors, the players and the solutions.
Our unique blend of financial expertise and strategic advice successfully identifies growth opportunities. We deliver insights and narratives that resonate with investors and ultimately drive value for our clients.
Why RNA Advisors?
Since 2015, RNA has provided over 300 clients in life sciences and healthcare with strategic decision analysis, valuation, and transactional support for thousands of transactions worth over $282 billion in asset and transaction value. Senior partners at RNA Advisors work actively on all client assignments with each having an average of 20+ years of life sciences sector experience across multiple subsectors.
Who We Advise
Our clients leverage our deep experience working with companies in need of support for strategic valuations, partnerships, financings, and transactions.
Value Assessment, Optimization & Creation
We create value for life sciences, healthcare, and technology companies. We work with private and public companies, health care systems and investors by providing market research, analytical modeling, valuation assessments, financial advisory consulting and transactional support for strategic deals and partnership opportunities.
Our clients come to us when they need strategic and transactional support for growth and to build marketplace competitive advantage:
Venture-Backed Private Companies
Venture-Backed Private Companies
Public Companies
Public Companies
Investors
Investors
Healthcare Systems & Universities
Healthcare Systems & Universities
Executives
Executives
What We Deliver
RNA Advisors provides valuation assessment, value optimization and strategic advisory support for a wide range of life science company needs across their full life cycle, from preclinical to exit or commercialization.
What Our Clients Say
RNA Advisors is committed to the highest standards of client service.
Misti Ushio, Digitalis Ventures
“RNA is always great to work with. They’re smart, they work fast, and they can jump in and get up to speed quickly. When we had critical needs, they’ve been able to really help us out in tough spots.”
Chris Parmentier, Virtue
“We have been working with RNA for several years. They are responsive, reliable, understand the nuances of our business and help us with modeling expertise that exceeds the capabilities within our corporate organization. We value them as an ecosystem partner and as a true extension of our operating team.”
David Chacko, Erasca
“The RNA team is responsive and efficient and understands the nuances of valuation as pertains to our sector, and we valued our partnership with them.”
Chris Vasquez, Biodesix
“The RNA team has been incredibly professional, very responsive to our on-going and sometimes tight turnaround valuation requests and has been an absolute pleasure to work with.”
Chris White, Healthcare Royalty
“We started working with the RNA team when we realized that the large branded firm that we were working with needed too much hand holding to understand our investments and the royalty industry. We switched to RNA because they understand the sector, are responsive and efficient, and are in the flow of the biopharma ecosystem.”
Gary Yeung, YK Bioventures
“RNA Advisors has been my go-to valuation firm for all the companies I have built. In my new capacity as a VC, I would recommend RNA Advisors to all my portfolio companies. RNA staff is one of the industry’s most capable and collaborative experts.”
Alex Mitchell, Dispatch Health
“I inherited the RNA team from the previous CFO and we’ve found them to be fantastic. They get healthcare, valuation, and they get the psychology of value just as much as the tools. They know how to get things done.”
Doug Hughes, Neotrack
“The RNA team is great. Sam and Kayvon have done an exceptional job working with my companies for over a decade. They deliver on time and I don’t have to spend time getting them up to speed because they already know healthcare and medtech.”
Bruce Peacock
“I’ve worked with the RNA team on a number of valuation matters, large and small. These guys know their stuff. Whether using them to assist with large licensing transaction negotiations to simple tax and financial reporting work, they understand and they deliver.”
Matt Zuga, High Cape
“RNA is my go to firm for diligence, modeling and valuation projects. Responsive…check, reliable…check, understand my investments and companies…check.”
Marshall Fordyce, Vera Therapeutics
“The RNA team helped us from inception through our IPO and beyond. They are one of the top firms that I know of at the intersection of valuation, biotech and finance. I’d recommend them for my life science venture-backed company colleagues.”
Robin LaChapelle, Arrivent
“The RNA team has helped us with tax and financial reporting-oriented valuation work. Its nice to work with a firm that not only understands the intricacies of reporting requirements but actually understands the drug development business.”
Stig Hansen, Kimia Therapeutics
“I’ve worked with the RNA team for over a decade across my current and previous companies. They are our go to valuation firm for valuation because they know the industry, are responsive and understand the nuances that drive transactions just as much as accounting.”
Kevin Slawin, Rapha Capital PE
“As the founder of Rapha Capital, an investment advisory, as well as the founder and/or board member of multiple private-stage companies in the biotech and medtech arenas, I’ve worked with RNA in many capacities, including target identification, diligence and in transaction advisory capacities. They are my “go to” firm to help me with all of these needs.”
Jake Frank, SmithRx
“I love the RNA team. They get healthcare and we’ve worked with the team both in valuation advisory capacities as well as on strategic projects for us as we take SmithRx to the next level. These guys get it!”
Roger Moody, Biocartis
“RNA knows the diagnostics space. From Nanosphere to Biocartis, RNA has been my valuation firm of choice. They are responsive, efficient and I know that they’ll deliver. I’ve been glad to see their success and growth. It’s well deserved.”
RNA Insights
Tune in here for our latest case studies, client news and upcoming events:
